---
figid: PMC8165182__fmed-08-600121-g0001
figtitle: An Overview of Lung Cancer in Women and the Impact of Estrogen in Lung Carcinogenesis
  and Lung Cancer Treatment
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8165182
filename: fmed-08-600121-g0001.jpg
figlink: /pmc/articles/PMC8165182/figure/F1/
number: F1
caption: Estrogen pathway in lung carcinogenesis and its relevance on therapy. Through
  non-genomic and genomic pathways, estrogen promotes cell proliferation, tumor growth,
  angiogenesis, cell migration, immunosuppressive responses, and tumor progression
  since tumor cells overexpressed ERβ. ARO expression maintains elevated E2 levels.
  The functional relationship between EGFR/EGF and E2/ER pathways sustain the E2 production
  through ARO expression and the EGFR activation in EGF absence. Preclinical studies
  have shown antiestrogen treatment efficacy, and in clinical trials, antiestrogen
  drugs have improved the clinical benefits of TKI and chemotherapy.
papertitle: An Overview of Lung Cancer in Women and the Impact of Estrogen in Lung
  Carcinogenesis and Lung Cancer Treatment.
reftext: Vianey Rodriguez-Lara, et al. Front Med (Lausanne). 2021;8:600121.
year: '2021'
doi: 10.3389/fmed.2021.600121
journal_title: Frontiers in Medicine
journal_nlm_ta: Front Med (Lausanne)
publisher_name: Frontiers Media S.A.
keywords: lung cancer | women | estrogens | antiestrogen medication | adenocarcimoma
automl_pathway: 0.9501236
figid_alias: PMC8165182__F1
figtype: Figure
redirect_from: /figures/PMC8165182__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8165182__fmed-08-600121-g0001.html
  '@type': Dataset
  description: Estrogen pathway in lung carcinogenesis and its relevance on therapy.
    Through non-genomic and genomic pathways, estrogen promotes cell proliferation,
    tumor growth, angiogenesis, cell migration, immunosuppressive responses, and tumor
    progression since tumor cells overexpressed ERβ. ARO expression maintains elevated
    E2 levels. The functional relationship between EGFR/EGF and E2/ER pathways sustain
    the E2 production through ARO expression and the EGFR activation in EGF absence.
    Preclinical studies have shown antiestrogen treatment efficacy, and in clinical
    trials, antiestrogen drugs have improved the clinical benefits of TKI and chemotherapy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - rasp
  - rin
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Src42A
  - Csk
  - Src64B
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - MKP-4
  - p38b
  - Egfr
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - shg
  - Gen
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - SRC
  - FGR
  - FYN
  - YES1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EGFR
  - CYP19A1
  - ESR2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - PPCDC
  - CXCR4
  - GEN1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - CDH1
  - FZR1
  - IGF1R
  - CXCL12
---
